Literature DB >> 11910363

Acquired myopathic intestinal pseudo-obstruction may be due to autoimmune enteric leiomyositis.

Tarja H Ruuska1, Riitta Karikoski, Virpi V Smith, Peter J Milla.   

Abstract

We describe a previously healthy boy who developed intestinal pseudo-obstruction following an episode of gastroenteritis at age 2 years. At presentation, the patient had mildly raised erythrocyte sedimentation rate and C-reactive protein level, and elevated antineutrophil cytoplasmic antibodies, antinuclear anti-DNA, and anti-smooth muscle antibodies. His electrogastrography was myopathic with no dominant frequency. First full-thickness intestinal biopsies showed a T lymphocytic myositis, particularly in the circular muscle. Steroid therapy resulted in clinical remission; cessation of steroids, in relapse. Further full-thickness biopsies showed an initial reduction in alpha-smooth muscle actin immunostaining in circular muscle myocytes and later atrophy and disappearance of many myocytes. Vascular and the remaining enteric smooth muscle cells showed HLA-DR and intercellular adhesion molecule 1 expression. These observations demonstrate the ability of enteric myocytes to take part in an inflammatory response and to change their phenotype, allowing them to act as antigen-presenting cells and to activate T cells. This and possible cytokine production by the myocytes play a role in their own destruction. This process responded to immunosuppressive therapy.

Entities:  

Mesh:

Year:  2002        PMID: 11910363     DOI: 10.1053/gast.2002.92396

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

1.  Primary intestinal autoimmune disease as a cause of chronic intestinal pseudo-obstruction.

Authors:  S Ghirardo; B Sauter; G Levy; I M Fiel; T Schiano; G Gondolesi
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 2.  Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy?

Authors:  E Oton; V Moreira; C Redondo; A Lopez-San-Roman; J R Foruny; G Plaza; E de Vicente; Y Quijano
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

3.  Chronic intestinal pseudo-obstruction due to lymphocytic intestinal leiomyositis: Case report and literature review.

Authors:  Keiichi Uchida; Kohei Otake; Mikihiro Inoue; Yuhki Koike; Kohei Matsushita; Toshimitsu Araki; Yoshiki Okita; Koji Tanaka; Katsunori Uchida; Noriko Yodoya; Shotaro Iwamoto; Katsuhiro Arai; Masato Kusunoki
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 4.  Pediatric Intestinal Pseudo-obstruction in the Era of Genetic Sequencing.

Authors:  Heidi E Gamboa; Manu Sood
Journal:  Curr Gastroenterol Rep       Date:  2019-12-17

5.  Proceedings of the 2018 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Vinicius Carreira; Caralyn S Labriola; Debabrata Mahapatra; Sean R McKeag; Matthias Rinke; Cynthia Shackelford; Bhanu Singh; Ashley Talley; Shannon M Wallace; Lyn M Wancket; Cynthia J Willson
Journal:  Toxicol Pathol       Date:  2018-10-03       Impact factor: 1.902

Review 6.  [Motility disorders of the esophagus].

Authors:  E Bruder; A-L Rougemont; R I Furlano; J F Schneider; J Mayr; F-M Haecker; K Beier; J Schneider; P Weber; T Berberich; G Cathomas; W A Meier-Ruge
Journal:  Pathologe       Date:  2013-03       Impact factor: 1.011

7.  Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series.

Authors:  C H Knowles; D B A Silk; A Darzi; B Veress; R Feakins; A H Raimundo; T Crompton; E C Browning; G Lindberg; J E Martin
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

8.  Generalized megaviscera of lupus: refractory intestinal pseudo-obstruction, ureterohydronephrosis and megacholedochus.

Authors:  Frederick-D Park; Jeffrey-K Lee; Ganga-D Madduri; Pradipta Ghosh
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

9.  Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction.

Authors:  M G Schäppi; V V Smith; P J Milla; K J Lindley
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 10.  New techniques in the tissue diagnosis of gastrointestinal neuromuscular diseases.

Authors:  Charles H Knowles; Joanne E Martin
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.